Bristol-Myers Squibb Co (NYSE:BMY) over-valued by 13%
Website | https://www.bms.com/ |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $146,362,662,912 |
Beta | 0.619786 |
Average Volume | $11,550,316 |
Last Dividend | 1.88% |
Price on Jul 27, 2022 | $74.46 |
Autochartist™ Valuation | $64.90 |
Conclusion |
13% over-valued |
Download Report |